Capital and Business Alliance with ストレックス株式会社
First written in FY2017. 2 of 4 entries say "Restated". Latest entry: FY2019-Q3.
1 other company's latest entry also says "Restated".
- FY2019-Q3RestatedAnnual report
「In collaboration with ストレックス株式会社, which manufactures and sells equipment related to regenerative medicine, we will develop the regenerative medicine and cell therapy fields into one of the core businesses of the 日本トリム Group.」
The policy of developing the regenerative medicine and cell therapy fields into one of the Group’s core businesses through collaboration with ストレックス株式会社 is being reaffirmed. - FY2018AdvancedAnnual report
「ストレックス株式会社 manufactures and sells equipment related to regenerative medicine and develops products that address the needs of researchers in the fields of regenerative and reproductive medicine. The company has steadily generated sales and profits.」
The company’s track record after the capital alliance with ストレックス株式会社 was presented, including product development for regenerative and reproductive medicine and the generation of sales and profits. - FY2018-Q1RestatedAnnual report
「In May, we entered into a capital alliance with ストレックス株式会社, which manufactures and sells medical equipment.」
The capital alliance with ストレックス株式会社 is being reaffirmed as a measure to strengthen the medical-related business structure. - FY2017First statedAnnual report
「In May, we entered into a capital and business alliance with ストレックス株式会社, which plans, develops, manufactures and sells equipment for pharmaceutical research and medical applications.」
A capital and business alliance was formed with ストレックス株式会社, which handles equipment for pharmaceutical research and medical applications.